COMMD10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.685200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.302400E-01
Normal-vs-Stage2
4.465800E-01
Normal-vs-Stage3
1.069810E-01
Normal-vs-Stage4
6.559000E-01
Stage1-vs-Stage2
3.727800E-01
Stage1-vs-Stage3
1.983790E-01
Stage1-vs-Stage4
7.021200E-01
Stage2-vs-Stage3
2.758400E-01
Stage2-vs-Stage4
8.958200E-01
Stage3-vs-Stage4
4.090400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.844600E-01
Normal-vs-AfricanAmerican
7.257800E-01
Normal-vs-Asian
2.277400E-01
Caucasian-vs-AfricanAmerican
8.233400E-01
Caucasian-vs-Asian
1.294630E-01
AfricanAmerican-vs-Asian
2.792000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.420800E-01
Normal-vs-Female
4.860400E-01
Male-vs-Female
6.096600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.912400E-01
Normal-vs-Age(41-60Yrs)
9.916200E-01
Normal-vs-Age(61-80Yrs)
3.556600E-01
Normal-vs-Age(81-100Yrs)
1.848610E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.741000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.622600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.940420E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.663500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.654000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.867400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.536600E-01
Normal-vs-Daily Drinker
4.351800E-01
Normal-vs-Weekly Drinker
8.911600E-02
Normal-vs-Occasional Drinker
9.088800E-01
Normal-vs-Social Drinker
8.680200E-01
Non Drinker-vs-Daily Drinker
9.960800E-01
Non Drinker-vs-Weekly Drinker
3.112000E-01
Non Drinker-vs-Occasional Drinker
6.643900E-02
Non Drinker-vs-Social Drinker
2.452800E-01
Daily Drinker-vs-Weekly Drinker
4.626400E-01
Daily Drinker-vs-Occasional Drinker
1.056800E-01
Daily Drinker-vs-Social Drinker
2.988800E-01
Weekly Drinker-vs-Occasional Drinker
1.765600E-02
Weekly Drinker-vs-Social Drinker
8.559700E-02
Occasional Drinker-vs-Social Drinker
6.292800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.272800E-01
Normal-vs-Grade 2
6.965200E-01
Normal-vs-Grade 3
6.876600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.311210E-01
Grade 1-vs-Grade 3
1.675570E-01
Grade 1-vs-Grade 4
3.272800E-01
Grade 2-vs-Grade 3
8.558600E-01
Grade 2-vs-Grade 4
6.965200E-01
Grade 3-vs-Grade 4
6.876600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.133800E-01
Normal-vs-NonDiabetic
6.061600E-01
Diabetic-vs-NonDiabetic
2.755400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.268330E-02
Normal-vs-NoPancreatitis
5.803600E-01
Pancreatitis-vs-NoPancreatitis
1.216590E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.226000E-01
Normal-vs-N1
4.858000E-01
N0-vs-N1
9.038200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.557600E-01
Normal-vs-TP53-NonMutant
7.563200E-01
TP53-Mutant-vs-TP53-NonMutant
2.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
